CPT1A and metabolic dysfunction-associated steatotic liver disease: A previous study has shown that Desulfovibrio can attenuate NAFLD by suppressing FASN expression, whereas our results showed that Desulfovibrio may attenuate NAFLD by mediating the 12-tridecenoic acid-ACC-CPT1A axis.